sb 203580 has been researched along with paclitaxel in 18 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 15 (83.33) | 29.6817 |
2010's | 3 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Henne, WA; Kularatne, SA; Low, PS; Santhapuram, HK; Vaitilingam, B; Venkatesh, C; Wang, K | 1 |
Bacus, SS; Gudkov, AV; Keyomarsi, K; Komarov, AP; Lowe, M; Lyass, L; Seger, R; Yarden, Y; Yung, Y | 1 |
Arvidsson, Y; Funa, K; Hamazaki, TS; Ichijo, H | 1 |
Horwitz, SB; Yang, CP | 1 |
Boldt, S; Kolch, W; Weidle, UH | 1 |
Bertino, JR; Li, W | 1 |
Birukova, A; Garcia, JG; Petrache, I; Ramirez, SI; Verin, AD | 1 |
Gil, JE; Kim, JH; Moon, EY; Oh, SY; Song, JH; Yeom, YI | 1 |
Babó, I; Harisi, R; Jeney, A; Kenessey, I; Oláh, J; Pogány, G; Timár, F | 1 |
Adyshev, D; Bogatcheva, NV; Mambetsariev, B; Moldobaeva, N; Verin, AD | 1 |
Li, Z; Lu, M; Xiao, L | 1 |
Deng, S; Hu, J; Lu, M; Xiao, L; Xu, Y | 1 |
Jou, I; Kim, HY; Park, JY; Park, SM | 1 |
Hendricks, M; Jesuthasan, S | 1 |
Babo, I; Harisi, R; Jeney, A; Kenessey, I; Olah, JN; Paku, S; Pogany, G; Timar, F | 1 |
Domoto, R; Kawabata, A; Nakashima, K; Nishibori, M; Sekiguchi, F; Tsubota, M; Wake, H; Yamanishi, H; Yamasoba, D | 1 |
Hu, Z; Lai, W; Li, R; Ma, Y; Shi, F; Yue, C; Zhao, M | 1 |
1 review(s) available for sb 203580 and paclitaxel
Article | Year |
---|---|
[Study of drugs against neoplastic metastasis].
Topics: Animals; Antineoplastic Agents; Cell Movement; Chromones; Deoxyuridine; Doxorubicin; Enzyme Inhibitors; Fatty Alcohols; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Morpholines; Neoplasm Metastasis; Paclitaxel; Pyridines; Ribavirin; Signal Transduction; Sirolimus | 2006 |
17 other study(ies) available for sb 203580 and paclitaxel
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs.
Topics: Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Glutamate Carboxypeptidase II; Glutarates; Humans; Ligands; Male; Molecular Targeted Therapy; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship; Urea | 2010 |
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Carcinoma; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Female; Flavonoids; G2 Phase; Humans; Imidazoles; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Mitosis; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Protein Serine-Threonine Kinases; Pyridines; Rats; Receptor, ErbB-2; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
ASK1 resistant neuroblastoma is deficient in activation of p38 kinase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; DNA; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kinetics; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Mutation; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Pyridines; Tumor Cells, Cultured | 2001 |
Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Antineoplastic Agents, Phytogenic; Butadienes; Cell Line; Enzyme Inhibitors; Gene Expression; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Proteins; Pyridines; Serine; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Threonine; Tumor Necrosis Factor-alpha | 2002 |
The role of MAPK pathways in the action of chemotherapeutic drugs.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2002 |
Fas-mediated signaling enhances sensitivity of human soft tissue sarcoma cells to anticancer drugs by activation of p38 kinase.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Caspase 9; Caspases; Cell Cycle; Cell Death; Cell Separation; Chalcone; Chalcones; Cytochrome c Group; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; fas Receptor; Flow Cytometry; Humans; Imidazoles; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Sarcoma; Signal Transduction; Soft Tissue Neoplasms; Time Factors; Tumor Cells, Cultured | 2002 |
The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability.
Topics: Actins; Adherens Junctions; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cytoskeleton; Electric Impedance; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Immunohistochemistry; Microtubules; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pulmonary Artery; Pyridines; Tumor Necrosis Factor-alpha | 2003 |
ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Imidazoles; Mice; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Pyridines; ras Proteins; RNA, Small Interfering; Thymosin; Transfection | 2006 |
Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction.
Topics: 2-Methoxyestradiol; Actomyosin; Amides; Blood-Air Barrier; Cell Membrane Permeability; Endothelial Cells; Estradiol; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Microelectrodes; Microtubules; Models, Biological; Myosin-Light-Chain Kinase; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyridines; rho-Associated Kinases; Tubulin | 2007 |
The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; RNA, Messenger; Transfection; Tumor Suppressor Protein p53 | 2007 |
Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Female; Humans; Imidazoles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Signal Transduction | 2008 |
GM1 induces p38 and microtubule dependent ramification of rat primary microglia in vitro.
Topics: Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; G(M1) Ganglioside; Gangliosides; Imidazoles; Interferon-gamma; Lipopolysaccharides; Microglia; Microscopy, Confocal; Microtubules; Nerve Growth Factor; Neurotrophin 3; Nocodazole; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tubulin Modulators | 2008 |
PHR regulates growth cone pausing at intermediate targets through microtubule disassembly.
Topics: Animals; Anthracenes; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Death-Associated Protein Kinases; Dose-Response Relationship, Drug; Electroporation; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Growth Cones; Imidazoles; MAP Kinase Kinase 4; Membrane Proteins; Mice; Mice, Transgenic; Microtubules; Neurons; Nocodazole; Paclitaxel; Phosphorylation; Prosencephalon; Pyridines; Signal Transduction; Spinal Cord; Tubulin Modulators; Zebrafish; Zebrafish Proteins | 2009 |
Differential inhibition of single and cluster type tumor cell migration.
Topics: Adolescent; Bone Neoplasms; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chromones; Deoxyuridine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Flavonoids; Humans; Imidazoles; Male; Morpholines; Okadaic Acid; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Tumor Cells, Cultured | 2009 |
Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
Topics: Acetylcysteine; Animals; Antibodies; Cells, Cultured; Clodronic Acid; Coculture Techniques; Ganglia, Spinal; HMGB1 Protein; Hyperalgesia; Imidazoles; Macrophages; Male; Membrane Proteins; Mice; Minocycline; Neurons; p300-CBP Transcription Factors; Paclitaxel; Peripheral Nervous System Diseases; Phosphoproteins; Phosphorylation; Proline; Pyridines; Pyruvates; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, CXCR4; Recombinant Proteins; Sciatic Nerve; Thiocarbamates; Thrombomodulin; Up-Regulation | 2018 |
Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Imidazoles; MAP Kinase Signaling System; Membrane Glycoproteins; Microfilament Proteins; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines | 2019 |